Combination of paclitaxel and radiation: Genotoxicity in vitro in four mammalian cell lines

Cancer Letters

Volumn 145, Issue 1-2, 1999, Pages 29-33

  Preisler, Verena K ^a   Wück, Daniela ^a,b   Stopper, Helga ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Micronuclei; Paclitaxel; Radiation

Indexed keywords

PACLITAXEL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE; COMBINED MODALITY THERAPY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICRONUCLEUS TESTS; PACLITAXEL; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

ANIMALIA; MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0344172189     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00217-7     Document Type: Article

References (18)

1. Arbuck S.G., Blaylock B.A. Taxol: clinical results and current issues in development. Suffness M. Taxol: Science and Applications. 1995;379-415 CRC Press, Boca Raton.
2. Runowicz C.D., Wiernik P.H., Einzig A.I. Taxol in ovarian cancer. Cancer. 71:1993;1591-1596.
3. Rowinsky E.K., Cazenave L.A., Donehower. Taxol: A novel investigational antimicrotubule agent. J. Natl. Cancer Inst. 82:1990;1247-1259.
4. Frei E. III. Combination cancer therapy: presidential address. Cancer Res. 32:1972;2593-2607.
5. Horwitz S.B. Taxol (paclitaxel). Mechanism of action. Ann. Oncol. 5:1994;53-56.
6. Horwitz S.B. Mechanism of action of Taxol. Trends Pharmacol. Sci. 13:1992;134-136.
7. Cook J.A., Teague D., Fisher J. Radiosensitization of Chinese hamster V79 cells by taxol. Radiat. Oncol. Invest. 1:1993;103-110.
8. Sinclair W.K. Cyclic X-ray responses in mammalian cells in vitro. Radiat. Res. 33:1968;620-643.
9. Tishler R.B., Schiff P.B., Geard C.R., Hall E.J. Taxol: A novel radiation sensitizer. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;613-617.
10. Miller B., Locher F., Seelbach A., Stopper H., Utesch D., Madle S. Evaluation of the in vitro micronucleus test (MNT) as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group 'in vitro MNT'. Mutat. Res. 410:1998;81-116.
11. Stopper H., Müller S.O. Micronuclei: biological endpoint for genotoxicity. Toxicol. in Vitro. 11:1997;661-667.
12. ®). Int. J. Radiat. Oncol. Biol. Phys. 29:1994;559-564.
13. Preisler V.K., Stopper H., Friedl R., Pfreundner L., Hoppe F., Hagen R. Cytotoxic and genotoxic effects of paclitaxel (Taxol) and radiation in a squamous carcinoma cell line of the larynx. Acta Otolaryngol. 118:1998;600-605.
14. Tishler R.B., Geard C.R., Hall E.J., Schiff P.B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52:1992;3495-3497.
15. Choy H., Rodriguez F.F., Koester S., et al. Investigation of taxol as a potential radiation sensitizer. Cancer. 71:1993;3774-3778.
16. Steren A., Sevin B., Perras J., et al. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol. Oncol. 48:1993;252-258.
17. Geard C.R., Jones J.M. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;565-569.
18. Geard C.R., Jones J.M., Schiff P.B. Taxol and radiation. J. Natl. Cancer Inst. 15:1993;89-94.